FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

411530000: Insulin glulisine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2466981010 Insulin glulisine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2473143013 Insulin glulisine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49961000195116 insulina glulisina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
818001000172111 insuline glulisine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64141000195111 Insulin glulisin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin glulisine (substance) Is a Rapid-acting insulin false Inferred relationship Some
Insulin glulisine (substance) Is a Short-acting insulin false Inferred relationship Some
Insulin glulisine (substance) Is a Human insulin true Inferred relationship Some
Insulin glulisine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing insulin glulisine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glulisine (substance) Inferred relationship Some 1
Insulin glulisine 100units/mL injection 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glulisine (substance) Inferred relationship Some
Insulin glulisine 100iu/mL injection 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glulisine (substance) Inferred relationship Some
Product containing insulin glulisine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glulisine (substance) Inferred relationship Some 1
Product containing precisely insulin glulisine 1000 unit/10 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin glulisine (substance) Inferred relationship Some 1
Product containing precisely insulin glulisine 1000 unit/10 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Insulin glulisine (substance) Inferred relationship Some 1
Product containing only insulin glulisine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glulisine (substance) Inferred relationship Some 1
Product containing only insulin glulisine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glulisine (substance) Inferred relationship Some 1
Insulin glulisine 100 unit/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Insulin glulisine (substance) Inferred relationship Some 1
Insulin glulisine 100 unit/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Insulin glulisine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start